首页|期刊导航|中医肿瘤学杂志|免疫检查点抑制剂相关性肺炎的临床特征及中医病机初探

免疫检查点抑制剂相关性肺炎的临床特征及中医病机初探OA

Clinical Characteristics of Checkpoint Inhibitor Pneumonitis and Preliminary Exploration of Its Pathogenesis in Traditional Chinese Medicine

中文摘要英文摘要

目的 分析不同级别免疫检查点抑制剂相关性肺炎(checkpoint inhibitor pneumonitis,CIP)患者的临床特征,并探讨其中医病机以丰富免疫治疗相关不良反应(immune-related adverse events,irAEs)的中医认识.方法 选择2022年1月至2024年12月于广州中医药大学第一附属医院肿瘤中心住院并发生CIP的患者作为研究对象.收集患者临床资料,将患者分为低级别组(n=27)与高级别组(n=28),分析比较两组的临床特征、检验指标、中医四诊信息、证型、治疗及预后.结果 共收集55例CIP患者.高级别组吸烟史比例、中性粒细胞计数高于低级别组,而血小板计数低于低级别组(均P<0.05).中医特征方面,气促与黄苔是高级别CIP的相关体征;证型分布上,低级别组以痰湿证为主(48.15%),高级别组以气虚证为主(32.14%);中医病机中实以痰湿、热毒为主,虚以气虚、阴虚为主;治疗上,痰湿证以二陈汤为基础方,气虚证以六君子汤为基础方.低级别组预后良好,高级别组预后较差,低级别组完全缓解或好转的患者比例高于高级别组(74.07%vs 32.14%).单纯中药治疗组与中西医结合治疗组的中位好转时间分别为26(19,50)天与30(24,57)天.6例接受免疫再挑战的患者中1例(16.67%)复发.结论 CIP患者出现症状加重、血小板计数降低、中性粒细胞升高,可能提示病情恶化.CIP中医病机以本虚标实为特点,痰湿证是CIP患者中最常见的证型.中药联合标准的西医治疗有助于缩短CIP的病程,降低复发率,尤其为低级别CIP的治疗提供了优势选择.

Objective To analyze the clinical characteristics of patients with checkpoint inhibitor pneumonitis(CIP)of different grades and explore traditional Chinese medicine(TCM)pathogenesis to enrich the TCM understanding of immune therapy-related adverse reactions(irAEs).Methods Patients who were hospitalized and underwent CIP at the Cancer Center of The First Affiliated Hospital of Guangzhou University of Chinese Medicine from January 2022 to December 2024 were selected as the study subjects.Clinical data of the patients were collected,and they were divided into a low-grade group(n=27)and a high-grade group(n=28).The clinical characteristics,laboratory test indicators,TCM four diagnostic information,syndrome types,treatment approaches,and prognoses of the two groups were analyzed and compared.Results A total of 55 CIP patients were collected.The proportion of patients with a smoking history and the neutrophil count in the high-grade group were higher than those in the low-grade group,while the platelet count was lower(all P<0.05).In terms of TCM features,shortness of breath and yellow tongue coating were associated with high-grade CIP.Regarding syndrome type distribution,the low-grade group was mainly characterized by phlegm-dampness syndrome(48.15%),while the high-grade group was mainly characterized by qi-deficiency syndrome(32.14%).The TCM pathogenesis involved excess syndromes primarily manifested as phlegm-dampness and heat-toxicity,and deficiency syndromes manifested as qi-deficiency and yin-deficiency.For treatment,the basic TCM formulas were Erchen Decoction in phlegm-dampness syndrome and Liujunzi Decoction in qi-deficiency syndrome.The prognosis was favorable in the low-grade group and poorer in the high-grade group,and the proportion of patients achieving complete remission or improvement in the low-grade group was higher than that in the high-grade group(74.07%vs 32.14%).The median time to improvement was 26(19,50)days in the TCM-only treatment group and 30(24,57)days in the integrated Chinese and Western medicine treatment group.Among 6 patients who underwent immunotherapy rechallenge,only 1(16.67%)experienced recurrence.Conclusion Aggravated symptoms,decreased platelet count,and elevated neutrophils in CIP patients may indicate the potential for disease deterioration.The TCM pathogenesis of CIP is characterized by deficiency in the root and excess in the manifestation,with the phlegm-dampness syndrome being the most common among CIP patients.The combination of traditional Chinese medicine with standard Western medical treatment helps shorten the course of CIP and reduce the recurrence rate,providing an advantageous option for the treatment of low-grade CIP.

徐卉妤;卢冬彦;黄小芷;叶小卫

广州中医药大学第一临床医学院,广东 广州 510405广州中医药大学第一附属医院肿瘤中心,广东 广州 510405广州中医药大学第一临床医学院,广东 广州 510405广州中医药大学第一附属医院肿瘤中心,广东 广州 510405

医药卫生

免疫检查点抑制剂相关性肺炎免疫检查点抑制剂药物不良反应中医病机

checkpoint inhibitor pneumonitisimmune checkpoint inhibitorsadverse drug reactionstraditional Chinese medicine pathogenesis

《中医肿瘤学杂志》 2026 (1)

75-83,9

广东省药品监督管理局科技创新项目(编号:2023YDZ11).

10.19811/j.cnki.ISSN2096-6628.2026.01.010

评论